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Summary 
Consideration of psychological distress in long term endocrine conditions is of vital 
importance given the prevalence of anxiety and depression in such disorders. Poor 
mental health can lead to compromised self-care, higher utilisation of health services, 
lower rates of adherence, reduced quality of life and ultimately poorer outcomes. 
Adjuvant psychological therapy offers an effective resource to reduce distress in 
endocrinological disorders. While the vast majority of work in this area has focused 
on psychological screening and intervention in diabetes, identification and recognition 
of psychological distress is equally important in other endocrinological conditions, 
with supportive evidence in Polycystic Ovary Syndrome and Addison’s disease. 
Referral pathways and recommendations set out by UK guidelines and the 
Department of Health mandate requires greater attention across a wider range of long 
term endocrine disorders to facilitate improved quality of life and health outcome. 
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Clinical case 
Patient A, a female in her 40s with a diagnosis of well-controlled Addison’s Disease 
presents as reassurance seeking and highly anxious at consultation.  Due to anxieties 
focussed around early detection of infections to prevent Addisonian crisis, Patient A 
frequently attends the local Emergency Department (ED) at the point at which she 
detects changes in bodily variations, such as palpitations, dizziness, feeling hot,  and 
physical sensations, which she often interprets as signs of illness. This is accompanied 
by high levels of psychological distress. In a 12 month period, Patient A had been 
admitted through the ED on six occasions, with an average of five days per stay.  
Admission initially decreases distress, however this reinforces use of the ED as a 
coping strategy. Despite less than 50% of attendances confirming presence of 
infection, Patient A continues to use emergency services and additional outpatient 
appointments to reduce anxiety and seek reassurance when she suspects a pending 
infection. Patient A’s distress has become unmanageable.   
 
Introduction 
Psychological distress in response to significant health problems is not only common but 
‘normal’ and understandable: the disruption to life trajectories and impact on every domain of 
life makes adjustment difficult. Signs of compromised psychological wellbeing within the 
medical setting often include behavioural changes such as ineffective self-management, poor 
attendance to medical appointments and reduced treatment adherence1. In clinic, the 
distressed patient may present as tearful, withdrawn, low in mood, with reductions in sleep 
and appetite; they may appear anxious/panicky, excessively worried and frequently seeking 
reassurance, or a combination of these and other symptoms (see box 1).  For those most 
affected, normal day-to-day activities will become a challenge and enjoyment of life will be 
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much reduced, yet many will present to the clinic with a ‘brave’ face. Distress is not always 
immediately evident, but can be revealed with a gentle and general line of enquiry: ‘…and 
how have things been?’ – an important question that should be asked of all of our patients.  
 
Psychological distress has been detected in up to 81% of endocrine conditions, with half 
representing low mood and a third anxiety related2. Prevalence of health related anxiety has 
been reported as particularly high in endocrine patients compared to the general population3, 
which is unsurprising given the potentially life-threatening nature of many endocrine 
conditions and the importance of hypervigilance to bodily changes and health status.  
 
The reciprocal relationship between physical and mental health is well documented: poor 
mental health leads to compromised self-care, higher utilisation of health services, lower rates 
of adherence, reduced quality of life and ultimately poorer outcomes1. Thus, long term 
conditions (LTCs) complicated by psychological distress require additional consideration. A 
recent report by the Kings Fund Centre for Mental Health1 suggests that between 12-18% of 
expenditure associated with LTCs in the UK is linked to poor mental health and well-being; 
integrated physical and mental health care would undoubtedly better meet the needs of 
patients and support the UK National Health Service (NHS) to meet the Quality, Innovation, 
Production and Prevention (QIPP) challenge as recommended. From the patient or clinician 
perspective, psychological and emotional wellbeing in LTCs has been a growing priority in 
recent years, with a particular focus on increasing self-management in the community and 
high quality care for all, including a holistic view of health and mental health1,4  
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What are the psychophysiological factors to take into account in long-term endocrine 
conditions? 
The interaction between biological, psychological and social aspects of long term endocrine 
conditions presents a complex clinical problem: symptoms commonly associated with the 
psychological presentation of anxiety and depression are similar to those attributed to the 
physical manifestations of prodromal, acute and sequale phases of an endocrine condition5. 
Indeed, in some cases, diagnosis of endocrine conditions have been overlooked by clinicians 
when presentation of psychological symptoms have masked changes in underlying physical 
symptoms6. 
 
Yet this complexity also provides a potential route to effective treatment. The 
biopsychosocial framework 7,8, well established in the context of health and clinical 
psychology offers a theoretical extension to the biomedical model to emphasise the 
importance of the interplay between biological (e.g. disease state, symptoms), psychological 
(e.g. mood, cognitions) and social factors (e.g. social support, socioeconomic status) to 
influence clinical outcomes. Such a framework broadens the ways in which the condition 
may be treated, provides a perspective that suggests greater potential for positive outcomes 
and efficacy in treatment9. A biopsychosocial approach is particularly prevalent and accepted 
in pain research for example but has just as much utility in endocrine conditions where a 
complex interplay between psychological factors and endocrine alteration operates. Central to 
consideration of the role of psychological and social factors in physical health is the concept 
of quality of life, a subjective evaluation used to describe how an individual evaluates their 
life experience at any point in time. Health-related quality of life refers to an individual’s 
subjective experience in relation to the condition or symptoms they are facing (for overview 
see 10). There are various ways to assess this subjective evaluation and a range of 
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standardised questionniares exist (e.g. SF-3611; WHOQOL-10012) that evaluate different 
domains including physical functioning, mental or psychological health, and social 
relationships.  
 
It is well known and accepted that psychological and social (psychosocial) factors, including 
the experience of and reactivity to stress, typified by an individual’s response to the demands 
of their life situation, can have significant impact on allostatic regulatory mechanisms13, 14. 
Disruption of stress response systems - the hypothalamic-pituitary-adrenal (HPA) axis and 
sympathetic adrenal medullary (SAM) system - and of the negative feedback mechanisms 
that underlie them, are not only observed as a result of endocrine pathology. Dysregulation is 
also seen in individuals experiencing chronic ongoing duress, particularly in the absence of 
supportive social networks or effective personal coping resources. Psychosocial disruption 
has been associated with dysregulation of diurnal cortisol patterns leading to lowered 
resistance to disease across a range of physical conditions including autoimmune9,15. Yet 
there is less documented evidence to describe the exact role of stress in endocrine conditions. 
Whilst stress may play an intrinsic contributory role in the onset and exacerbation of 
endocrine conditions such as diabetes16,17, the important issue in the current discussion is also 
the extent to which stress reduction may help patients regulate their endocrine condition and 
influence its ongoing management.  
 
There is evidence that despite cortisol replacement in cases such as Addisons disease, patient 
experience of stress remains intact and particular aspects of the physiological stress response 
persist18. Although cortisol is administered and controlled synthetically in cases of adrenal 
insufficiency, simulation of circadian variation in cortisol rhythm presents significant 
challenges. Glucocorticoid dysregulation resulting from lack of normal cortisol variation can 
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influence mood (anxiety and depression) and have implications for reduced health-related 
quality of life across a range of domains including physical and social functioning19,20. There 
is evidence to suggest not only that higher levels of hydrocortisone dosage are assocated with 
poorer health-related quality of life and mood in patients with adrenal insufficiency but also 
that manipulation of hydrocortisone administration to two rather than three times per day may 
be beneficial in respect to these outcomes as this more closely mirrors natural cortisol 
regulation20. That closer simulation of natural circadian rhythms in conditions of adrenal 
insufficiency is linked to better psychosocial outcomes and that psychosocial outcomes may 
further influence endocrine regulation and disease course requires further attention. In 
particular, attention has been drawn to the need for closer simulation of cortisol rhythm to 
focus on enabling an increase in the pre awakening hours20. Such solutions would maximise 
efficacy of medical regimens and psychosocial outcomes in reciprocal benefit. 
 
Psychological therapy: what are the guidelines and recommendations? 
 
The degree to which psychological aspects of wellbeing are considered in the UK National 
Institute for Care and health Excellence (NICE) guidance varies: Graves’ Disease, 
Hypothyroidism, Addison’s disease and Cushing’s Syndrome bear no mention of 
psychological wellbeing, despite known prevalence of depression and anxiety amongst these 
populations. Guidance for Hyperthyroidism and Polycystic Ovary Syndrome acknowledge 
the importance of emotional wellbeing, but little more. Guidance for the management of 
Diabetes recommends significant clinical input and care to address psychological and 
emotional wellbeing, outlining the necessity for early identification of sub-clinical levels of 
anxiety and depression, with particular reference to the importance of recognising an 
emerging eating disorder; guidance stipulates the need for clinicians involved in patient care 
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to be able to identify and refer on to specialist eating disorders clinics or for psychosexual 
interventions21 (see https://www.nice.org.UK for all guidance). However, a recent UK Care 
Quality Commission paper22 reported that 76% of patients are not offered psychological help 
despite recommendations in NICE guidance, with an overarching theme of outstanding need 
for emotional support voiced by patients. This indicates outstanding clinical need.  
  
The most commonly applied psychological model in treating distress associated with health 
problems is Cognitive Behavioural Therapy (CBT), which has been found to be effective for 
a range of physical health problems23 and is frequently endorsed within NICE 
guidance.  CBT has proven efficacy for common problems found in medical conditions such 
as mood related issues, anxiety, fatigue and pain24. CBT is a time-limited, goal orientated and 
collaborative intervention which is based on identifying unhelpful thoughts and assumptions 
which lead to behavioural and emotional responses that precipitate vicious cycles of distress. 
The intervention itself is individually tailored and formulation driven. For patients with 
medical problems, the goal of CBT is to adopt active self-management and develop a 
repertoire of strategies to facilitate positive physical and emotional wellbeing24.  Other 
approaches which have demonstrated effectiveness include ‘third-wave’ cognitive 
behavioural therapies, including Acceptance-Commitment Therapy and Mindfulness Based 
Cognitive Therapy. 
 
Psychological interventions are adapted to include disease specific characteristics, however 
the underpinning theory and clinical approach to treating all distressing bears a commonality: 
the central role of ‘meaning’. This ‘making sense’ of illness, i.e. what the illness means to the 
individual and their life at that time, plays a pivotal role in how individuals self-regulate, and 
how they respond to and manage their health. This self-regulation model initially developed 
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by Levental and colleagues in the 1980s25,  provides a useful framework for understanding 
social cognitions in long term illness and devising therapeutic approaches to improve 
medication adherence and quality of life.   
 
The vast majority of outcome studies examining psychological therapy for endocrine 
disorders focus on Diabetes. A recent systematic review26 reported that CBT is effective in 
treating anxiety, depression and glycemic control in the short term, with data to support long 
term benefits for depression in Diabetes. There is preliminary evidence to support adjuvant 
psychological therapy in Polycystic Ovaries Syndrome27 and Addison’s Disease28, but it is 
evident that despite clinical need, there are few studies reporting trials of psychological 
therapy to treat distress associated with endocrine conditions. A randomised controlled trial 
of CBT for health anxiety in medical conditions, including endocrine patients29, reported 
cost-neutral positive outcomes, offering a promising treatment option for patients who 
experience distress, particularly anxiety, associated with their health. The paucity of evidence 
in the field should denote outstanding clinical need, rather than lack of efficacy: 
psychological need in endocrine disorders have been unequivocally established and require 
addressing5. 
 
What is the role of the endocrinologist in assessing psychological wellbeing?  
 
The role of the endocrinologist in assessing psychological wellbeing is primarily one of  
vigiliance and as conduit. It is beyond the clinical remit of the endocrinologist to 
comprehensively assess mental health, however it is possible that the patient experiencing 
psychological distress may not be seen regularly elsewhere and thus there is a duty of care 
address an outstanding unmet clinical need (see box 1 for summary overview).  
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NICE guidance for Diabetes, and further guidance on ‘depression in adults with a chronic 
physical health problems’ (see NICE.org.UK) indicates that clinicians should routinely and 
directly ask patients about their emotional wellbeing at every appointment. NICE specifically 
recommend asking the following questions:  
 
• During the last month, have you often been bothered by feeling down, depressed or 
hopeless? 
• During the last month, have you often been bothered by having little interest or 
pleasure in doing things?  
 
 These questions specifically target low mood, however screening for anxiety related 
problems is also recommended:   
• During the last month, have you often been bothered by feeling worried, anxious or 
panicky?  
• During the last month have you had concerns about your ability to cope with everyday 
activities?  
 
If the patient responds ‘yes’ to one or more of these questions, NICE recommend considering 
onward referral for a fuller assessment of emotional wellbeing. Borderline answers should be 
probed further, and ‘watchful waiting’ employed if patients are not forthcoming yet 
difficulties are suspected. A brief discussion regarding any history of psychological 
difficulties will provide meaningful information as to whether a patient would benefit 
additional closer monitoring by the GP. 
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Reduced medication adherence, poor attendance and difficulties in effective self-management 
should all be taken as potential early signs of psychological difficulties, and may act as a 
trigger to explore the degree to which functioning is compromised, particularly if the 
clinician believes there is little more that can be done to promote more effective self-
management from a service point of view.   
 
Changes in sleep/appetite/mood/function and other signs of psychological difficulties (see 
box 1.) may also represent the onset of more complex mental health needs, which reiterates 
the necessity of recognising changes and symptoms early on, as per the NICE guidance, in a 
bid to optimise outcomes in both physical and mental health.  
 
Routine implementation of standardised screening questionnaires within specialist endocrine 
settings would identify patients with emerging and existing psychological difficulties in line 
with UK NICE recommendations for early recognition and assessment. Disorder specific 
measures such as the Problem Areas in Diabetes Questionnaire (PAID) are useful in 
assessing the functional impact of struggling to adjust to illness and can be applied to other 
related conditions. Scales such as these can be used as a baseline measure or ad-hoc to give a 
measure of emotional distress. Measures commonly used to assess mental health include the 
Physical Health Questionanire 9 (PHQ-9)30 and Generalized Anxiety Disorder-7 (GAD-7)31, 
which show reliability in physical health settings and due to common use are transferrable 
across health services. The Hospital Anxiety and Depression Scale (HADS)32 is specifically 
designed for use in medical settings and reports cross-specialty reliability. Due to the high 
prevalence of health anxiety3 in endocrine disorders and recent evidence indicating the 
efficacy and cost-effectiveness of psychological interventions in medical clinics29, the authors 
suggest Health Anxiety Inventory (HAI)33 for screening purposes. Previous research has 
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identified that health anxiety has distinct clinical features which may not be sensitively 
detected though the use of a generic anxiety measure34.   
 
The primary purpose of assessing emotional wellbeing on routine basis is to allow for early 
detection and treatment of a range of difficulties, including more severe and enduring mental 
health issues.  Identification and integration of physical and mental health problems have 
become a priority on an international scale: recent developments in the USA private 
healthcare system35 and proposed actions within the World Health Organisation (WHO) 
European Mental Health Action Plan36 also recognise the need for better access and 
assessment of mental health within physical health.   
 
Who should be referred for psychological therapy? 
 
In addition to simple screening questions to triage need for onward referral, other thresholds 
may apply: referral for psychological therapy should be offered at the point at which patients 
experience psychological distress that interferes with emotional wellbeing, self-management 
and when they themselves express the need for additional support in relation to self-
management or distress 24. This is particularly pertinent in cases where residual physical 
symptoms and psychological distress co-occur as addressing psychological wellbeing is 
likely to  improve rates of physical remission1.  The threshold for referral for a more 
specialist assessment to may appear low (i.e. feeling bothered by low mood/worry, reduced 
enjoyment and activity) however, research indicates that compromised psychological 
functioning significantly impacts effective self-management and thus these initial symptoms 
bear gravitas; NICE and WHO indicate that early detection and intervention is essential for 
better outcomes long term.   
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For more acute and severe mental health difficulties such as hearing voices, unshakeable or 
unusual beliefs, hallucinations, mania, risk/suicidal despair, patients should be refered to the 
GP on an urgent same day basis to ensure onward referral for specialist mental health 
assessment due to risk management issues.   
 
Communication between services is vitally important to the success of integrating physical 
and mental health5, therefore it is essential that information regarding patient wellbeing is 
communicated to the GP in routine letters, including questionnaire data where available.  
 
What services are available for the endocrine patient who experiences psychological 
difficulties? 
 
The UK NHS Mandate37 emphasises the importance of a smooth transition between services, 
which requires front line clinicians to possess the skills of detection and knowledge of 
services available. Indeed, the consideration of adjuvant psychological therapy in long term 
endocrine disorders has come at a timely point; the NHS landscape is now populated with a 
range of options for individuals who require the integration of both physical and mental 
health.  
 
The Improving Access to Psychological Therapies (IAPT)38 movement has evolved to deliver 
stepped care psychological support for individuals who experience anxiety and depression 
with a co-morbid long term health problem, integrating physical and mental health38. Due to 
the recent evolution of IAPT service into the LTC sphere, there is no data available from 
larger follow-up studies. Psychological therapies delivered by IAPT are underpinned by 
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empirically grounded evidence based treatments and endorsed by NICE, however the 
successful adaptation to LTCs is yet to be evidenced in respect to long term outcomes or 
disease specific outcomes.   
 
Where available, pathways to these services are usually through general practitioner referral, 
with some local services offering self-referral. The stepped care model implies a ‘least 
intervention first time’ approach, where patients can progress through steps of psychological 
therapy which increase in intensity at each stage, and are limited to the recommended 
treatment duration (dependent on the presenting problem).  The waiting times for IAPT 
services is set on a national level, with 3 days from first referral to booking an assessment, 10 
days from referral to assessment and a further 4 weeks to interventions.  
 
Clinical and health psychologists are often attached to specific medical specialities and offer 
an in-house option; they are able to provide highly specialised assessment and interventions 
tailored to the individual needs of medical patients presenting with a broad range of 
psychological distress, however availability will again vary depending on locality. Models of 
working are usually more flexible within clinical health psychology services, offering less 
contraints around clinical sessions available, and the option of multi-disciplinary working, 
which is usually not the case in IAPT. Assessment and treatment target waiting times for 
clinical health psychology services may be set on a local or service level, or confer to NHS 
England’s 18 week target but in reality patients are seen sooner. Stepped care working can 
also be seen in clinical health settings as they are in IAPT, with equivalent bibliotherapy, 
group work and individual therapy options emerging.  
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In contrast to the IAPT LTC services, clinical and health psychologists are usually embedded 
within a medical setting and hold specialist expertise pertaining to that difficulty; this is not 
the case in IAPT LTC services where the dominant focus is mental health needs within the 
context of health problems. Indeed, while Diabetes has been identified as a target group for 
IAPT LTC, specialist knowledge of the aforementioned psychophysiology of the endocrine 
system is unlikely to be available. Notwithstanding this, IAPT LTC services represent a 
movement towards acknowledging the psychological impact of physical health problems: a 
highly skilled and efficient workforce and services underpinned by evidence-based 
approaches should be embraced as an additional tool to support those struggling to adapt to 
illness, particularly given impressive wait list targets.   
 
In addition to IAPT services and clinical and health psychologists in health settings, 
community mental health and services are also available for patients who are experiencing 
severe and enduring mental health problems, and should be accessed through the GP. While 
clinical and health psychologists embedded within medical settings are highly trained to work 
therapeutically integrating physical and mental health care, if mental health is considered the 
dominant concern (as opposed to physical health), then a referral back to the the GP for 
mental health assessment would be prudent to complement and optimise physical healthcare.  
 
Clinical case: outcome 
Patient A was referred to a clinical health psychologist working in an acute hospital 
setting. A brief 12-session course of CBT focussing on health related anxiety yielded 
reliable and clinically significant outcomes in respect to reductions in psychological 
distress and health service utility: in the 12 months following intervention Patient A 
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was admitted to the ED on zero occasions and maintained routine hospital 
attendances22.  
  
Conclusions  
Psychological distress in long term endocrine conditions is common and associated with 
compromised quality of life, elevated use of health services and poorer health outcomes.  
 
Due to the complex interplay between biological, psychological and social factors in 
endocrine disorders, symptoms associated with anxiety and depression could easily be missed 
by clinicians.  Anxiety and depression are amenable to psychological therapies with or 
without a physical health problem, with vast bodies of research underpinning the application 
of psychological theory to health problems. Psychological therapy is increasingly accessible 
through IAPT services or clinical health psychology in medical settings in the UK, however 
the availability of all psychological and mental health services vary within the UK and 
throughout Europe39 and the USA35 despite similar underpinning principles of better 
integrating physical and mental healthcare40. 
 
Identification and early detection of psychological difficulties should be considered as part of 
the core business of clinicians in endocrinology: the true integration of physical and mental 
health is vital to the optimisation of outcomes1. This can be achieved through implementation 
of brief screening measures, an awareness of services and referral pathways and, most 
importantly, a compassionate approach to each individual patient and their needs. Distress, 
here, is normal.   
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Box 1.  
Signs and symptoms associated with psychological distress  
- Low mood, tearful, hopelessness 
- Excessive worry, anxiety/panic  
- Lack of interpersonal  engagement  
- Poor sleep and/or appetite  
- Poor treatment adherence  
- Repeated clinic non-attendance  
- Problems carrying out normal day-to-day tasks   
- Reported difficulties in effective self-management 
- Reduced self-efficacy and functioning 
- Poor self-car (e.g. dressed inappropriate to weather, unkempt) 
 The role of the endocrinologist: 
- Vigilance to signs of psychological distress 
- Assess emotional wellbeing using NICE recommended screening 
questions and routine clinic review 
- Consider routine use of screening questionnaires to inform assessment of 
wellbeing  
- Routinely communicate information relating to emotional wellbeing to 
GP as case holder 
- Awareness of services and pathways for patients who warrant adjuvant 
psychological therapy  
- Refer to GP if onward referral for psychological therapy or mental health 
assessment if indicated 
 
  
